✦ LIBER ✦

Neurobiological Elements of Cognitive Dysfunction in Down Syndrome: Exploring the Role of APP

✍ Scribed by Martha Millan Sanchez; Sietske N. Heyn; Devsmita Das; Sarah Moghadam; Kara J. Martin; Ahmad Salehi

Book ID: 119199035
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 842 KB
Volume: 71
Category: Article
ISSN: 0006-3223
DOI: 10.1016/j.biopsych.2011.08.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cognitive dysfunction and the neurobiolo

Cognitive dysfunction and the neurobiology of ageing in cats

✍ D. Gunn-Moore; K. Moffat; L.-A. Christie; E. Head 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB

Evidence against the overexpression of A

Evidence against the overexpression of APP in down syndrome

✍ Francesca Argellati; Sara Massone; Cristina d'Abramo; Umberto M. Marinari; Maria 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

Donepezil for treatment of cognitive dys

Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10–17

✍ Priya S. Kishnani; James H. Heller; Gail A. Spiridigliozzi; Ira Lott; Luis Escob 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 2 views

P2-014: Dysregulation of brain APP in th

P2-014: Dysregulation of brain APP in the Ts65Dn Down syndrome mouse

✍ Jennifer H.K. Choi; Nichole S. Diaz; Matthew J. Mazzella; Jesse N. Peterson; Ann 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Exploring the correlates of impaired non

Exploring the correlates of impaired non-word repetition in Down syndrome

✍ Peter. Cairns; Christopher. Jarrold 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

The emergence of pharmacotherapies for c

The emergence of pharmacotherapies for cognitive function in Down syndrome

✍ George T. Capone 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

Capone GT. 2010. The emergence of pharmacotherapies for cognitive function in Down syndrome.